Dashboard
Manage Tickers

PFEPFIZER INC

NYSE pfizer.com


$ 28.28 $ 0.50 (1.8 %)    

Wednesday, 08-May-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 28.27
$ 27.73
$ 0.00 x 0
$ 0.00 x 0
$ 27.55 - $ 28.34
$ 25.20 - $ 38.81
38,646,310
na
161.05B
$ 0.57
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-08-2023 10-01-2023 10-Q
4 08-09-2023 07-02-2023 10-Q
5 05-10-2023 04-02-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-09-2022 10-02-2022 10-Q
8 08-10-2022 07-03-2022 10-Q
9 05-11-2022 04-03-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-12-2021 10-03-2021 10-Q
12 08-12-2021 07-04-2021 10-Q
13 05-13-2021 04-04-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-27-2020 10-Q
16 08-06-2020 06-28-2020 10-Q
17 05-07-2020 03-29-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-07-2019 09-29-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 07-01-2018 10-Q
25 05-10-2018 04-01-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-09-2017 10-01-2017 10-Q
28 08-10-2017 07-02-2017 10-Q
29 05-11-2017 04-02-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-10-2016 10-02-2016 10-Q
32 08-11-2016 07-03-2016 10-Q
33 05-12-2016 04-03-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-05-2015 09-27-2015 10-Q
36 08-06-2015 06-28-2015 10-Q
37 05-07-2015 03-29-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-28-2014 10-Q
40 08-07-2014 06-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential
Elon Musk Breaks Ranks With GOP By Praisin...
05/09/2024 09:01:47

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

pfizer-agrees-to-settle-over-10000-lawsuits-about-cancer-risks-associated-with-discontinued-heartburn-drug-zantac
Pfizer Agrees To Settle Over 10,000 Lawsui...
05/08/2024 18:58:30

Pfizer settles 10,000 Zantac lawsuits over cancer risks, but challenges remain. Details undisclosed. Sanofi's $100 million+...

second-death---pfizer-reports-young-boys-death-after-one-year-of-gene-therapy-treatment-in-muscle-wasting-disorder-trial
Second Death - Pfizer Reports Young Boy's ...
05/08/2024 17:09:46

A young patient passed away from cardiac arrest after receiving Pfizer's experimental gene therapy for Duchenne muscular dy...

jim-cramer-advises-investors-to-brace-for-economic-slowdown-shares-tips-to-maintain-balanced-portfolio-im-not-telling-you-to-relax
Jim Cramer Advises Investors To Brace For ...
05/08/2024 06:26:57

Jim Cramer, the host of CNBC's "Mad Money," has warned investors about the current state of the economy and suggest...

Core News & Articles
Sarepta Therapeutics Shares Move Higher; T...
05/07/2024 19:52:38

https://www.statnews.com/2024/05/07/duchenne-muscular-dystrophy-pfizer-gene-therapy-boy-dies/

watching-pfizer-shares-traders-circulating-stat-news-report-young-boy-dies-in-trial-for-pfizer-duchenne-gene-therapy
Watching Pfizer Shares; Traders Circulatin...
05/07/2024 19:31:05

https://www.statnews.com/2024/05/07/duchenne-muscular-dystrophy-pfizer-gene-therapy-boy-dies/

pfizers-options-frenzy-what-you-need-to-know
Pfizer's Options Frenzy: What You Need to ...
05/06/2024 20:45:35

whats-going-with-biontech-stock-on-monday
What's Going With BioNTech Stock On Monday?
05/06/2024 14:02:06

BioNTech reports Q1 loss, missing revenue expectations. Despite challenges, BioNTech aims for significant growth, fueled by inn...

pfizer-prospects-garner-mixed-sentiment-from-analysts-finally-the-pivot-investors-have-been-waiting-for
Pfizer Prospects Garner Mixed Sentiment Fr...
05/02/2024 19:15:39

Pfizer analysts from Goldman see a positive outlook on Padcev, Prevnar, and Vindaqel, but Nurtec and Oxbryta execution needs work.

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/02/2024 17:35:24

morgan-stanley-maintains-equal-weight-on-pfizer-raises-price-target-to-29
Morgan Stanley Maintains Equal-Weight on P...
05/02/2024 17:12:30

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $28 to...

live-on-cnbc-josh-brown-announces-he-has-doubled-down-on-pfizer
Live On CNBC, Josh Brown Announces He Has ...
05/02/2024 16:22:53

bmo-capital-reiterates-outperform-on-pfizer-raises-price-target-to-36
BMO Capital Reiterates Outperform on Pfize...
05/02/2024 14:27:15

BMO Capital analyst Evan David Seigerman reiterates Pfizer (NYSE:PFE) with a Outperform and raises the price target from $33...

pfizer-unusual-options-activity
Pfizer Unusual Options Activity
05/02/2024 13:46:48

investor-optimism-improves-slightly-following-fed-decision
Investor Optimism Improves Slightly Follow...
05/02/2024 06:37:50

carvana-enovix-pfizer-nio-tesla-why-these-5-stocks-are-on-investors-radars-today
Carvana, Enovix, Pfizer, Nio, Tesla: Why T...
05/02/2024 02:52:39

Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase a...

dow-jumps-200-points-following-fed-decision-pfizer-earnings-top-estimates
Dow Jumps 200 Points Following Fed Decisio...
05/01/2024 18:32:12

us-stocks-mixed-ahead-of-fed-meeting-chipmakers-tumble-after-amd-earnings-bitcoin-sinks-whats-driving-markets-wednesday
US Stocks Mixed Ahead Of Fed Meeting, Chip...
05/01/2024 17:07:02

Traders are treading cautiously in Wednesday’s session, seeking more clarity on the Federal Reserve’s stance with inflation rep...

pfizer-exec-says-co-is-progressing-on-retail-contracting-for-rsv-vaccine-rsv-vaccine-performance-was-in-line-with-expectations-in-qtr-patent-term-extension-if-granted-could-extend-us-exclusivity-for-heart-disease-drug-vyndamax-to-dec-2028
Pfizer Exec Says Co Is Progressing On Reta...
05/01/2024 14:54:37

-Conf. Call

pfizer-embraces-direct-to-consumer-model-for-covid-antiviral-says-comirnaty-revenues-continue-to-perform-consistently-with-expectations
Pfizer Embraces Direct-To-Consumer Model F...
05/01/2024 14:38:35

Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlov...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION